NCT00055718 2013-12-18
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
1 trialsDrug-Related Side Effects and Adverse Reactions × Silymarin × Other hematologic neoplasm × Clear all